Controlled major histocompatibility complex-T cell receptor signaling allows efficient generation of functional, antigen-specific CD8+ T cells from embryonic stem cells and thymic progenitors

Tissue Engineering - Part A

Volumn 16, Issue 9, 2010, Pages 2709-2720

  Lin, Jian ^a,b   Nie, Hui ^a   Tucker, Phillip W ^b   Roy, Krishnendu ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELL MEMBRANES; CYTOLOGY; SIGNALING;

CYTOTOXIC T LYMPHOCYTES; DIFFERENTIATION STRATEGIES; EFFICIENT METHOD; EMBRYONIC STEM CELLS; EMBRYONIC STEMS; GENE REARRANGEMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE EMBRYONIC STEM CELLS; PROGENITOR CELL; RECOMBINATION ACTIVATING GENES; RETROVIRAL TRANSDUCTION; STROMAL CELLS; T CELL RECEPTOR; T CELLS; TARGET CELLS; TETRAMERS;

STEM CELLS;

ANIMAL; ARTICLE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; FEMALE; FLOW CYTOMETRY; GENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYMUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FEMALE; FLOW CYTOMETRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMUS GLAND;

EID: 77956086184     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0707     Document Type: Article

References (51)

1. Germain, R.N. T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol 2, 309, 2002.
2. Singer, A., Adoro, S., and Park, J.H. Lineage fate and intense debate: myths, models and mechanisms of CD4-versus CD8-lineage choice. Nat Rev Immunol 8, 788, 2008.
3. Fontaine, P., Roy-Proulx, G., Knafo, L., Baron, C., Roy, D.C., and Perreault, C. Adoptive transfer of minor histocompati-bility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med 7, 789, 2001.
4. Schultze, J.L., Anderson, K.C., Gilleece, M.H., Gribben, J.G., and Nadler, L.M. A pilot study of combined immunother-apy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2. Br J Haematol 113, 455, 2001.
5. Galea-Lauri, J., Darling, D., Mufti, G., Harrison, P., and Farzaneh, F. Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunol Immunother 51, 299, 2002.
6. Van Rhee, F., and Barrett, J. Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation. Cytotherapy 4, 3, 2002.
7. Engleman, E.G. Dendritic cell-based cancer immunotherapy. Semin Oncol 30, 23, 2003.
8. Armstrong, A.C., Dermime, S., Mulryan, K., Stern, P.L., Bhattacharyya, T., and Hawkins, R.E. Adoptive transfer of anti-idiotypic T cells cure mice of disseminated B cell lym-phoma. J Immunother 27, 227, 2004.
9. Morgan, R.A., Dudley, M.E., Wunderlich, J.R., Hughes, M.S., Yang, J.C., Sherry, R.M., Royal, R.E., Topalian, S.L., Kammula, U.S., Restifo, N.P., Zheng, Z., Nahvi, A., de Vries, C.R., Rogers-Freezer, L.J., Mavroukakis, S.A., and Rosenberg, S.A. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314, 126, 2006.
10. Maus, M.V., Thomas, A.K., Leonard, D.G., Allman, D., Addya, K., Schlienger, K., Riley, J.L., and June, C.H. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat Biotechnol 20, 143, 2002.
11. \+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers. Tumour Biol 28, 70, 2007.
12. Oelke, M., Maus, M.V., Didiano, D., June, C.H., Mackensen, A., and Schneck, J.P. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nat Med 9, 619, 2003.
13. Daley, G.Q. From embryos to embryoid bodies: generating blood from embryonic stem cells. Ann N Y Acad Sci 996, 122, 2003.
14. Ying, Q.L., Nichols, J., Chambers, I., and Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281, 2003.
15. Storb, R. Allogeneic hematopoietic stem cell transplantation\yesterday, today, and tomorrow. Exp Hematol 31, 1, 2003.
16. Little, M.T., and Storb, R. The future of allogeneic hemato-poietic stem cell transplantation: minimizing pain, maximizing gain. J Clin Invest 105, 1679, 2000.
17. Maris, M., and Storb, R. The transplantation of hematopoi-etic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases. Immunol Res 28, 13, 2003.
18. Storb, R.F., Lucarelli, G., McSweeney, P.A., and Childs, R.W. Hematopoietic cell transplantation for benign hematological disorders and solid tumors. Hematol Am Soc Hematol Educ Program 1, 372, 2003.
19. Schmitt, T.M., de Pooter, R.F., Gronski, M.A., Cho, S.K., Ohashi, P.S., and Zuniga-Pflucker, J.C. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat Immunol 5, 410, 2004.
20. Zhao, Y., Parkhurst, M.R., Zheng, Z., Cohen, C.J., Riley, J.P., Gattinoni, L., Restifo, N.P., Rosenberg, S.A., and Morgan, R.A. Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Res 67, 2425, 2007.
21. Varnum-Finney, B., Dallas, M.H., Kato, K., and Bernstein, I.D. Notch target Hes5 ensures appropriate Notch induced T-versus B-cell choices in the thymus. Blood 111, 2615, 2008.
22. Varnum-Finney, B., Brashem-Stein, C., and Bernstein, I.D. Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood 101, 1784, 2003.
23. Taqvi, S., Dixit, L., and Roy, K. Biomaterial-based notch signaling for the differentiation of hematopoietic stem cells into T cells. J Biomed Mater Res A 79, 689, 2006.
24. La Motte-Mohs, R.N., Herer, E., and Zuniga-Pflucker, J.C. Induction of T-cell development from human cord blood hematopoietic stem cells by delta-like 1 in vitro. Blood 105, 1431, 2005.
25. Schmitt, T.M., and Zuniga-Pflucker, J.C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17, 749, 2002.
26. Besseyrias, V., Fiorini, E., Strobl, L.J., Zimber-Strobl, U., Dumortier, A., Koch, U., Arcangeli, M.L., Ezine, S., Macdo-nald, H.R., and Radtke, F. Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. J Exp Med 204, 331, 2007.
27. Mandal, M., Borowski, C., Palomero, T., Ferrando, A.A., Oberdoerffer, P., Meng, F., Ruiz-Vela, A., Ciofani, M., Zuniga-Pflucker, J.C., Screpanti, I., Look, A.T., Kors-meyer, S.J., Rajewsky, K., von Boehmer, H., and Aifantis, I. The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med 201, 603, 2005.
28. Terra, R., Louis, I., Le Blanc, R., Ouellet, S., Zuniga-Pflucker, J.C., and Perreault, C. T-cell generation by lymph node resident progenitor cells. Blood 106, 193, 2005.
29. \+ T cells. Clin Immunol 106, 16, 2003.
30. Bodinier, M., Peyrat, M.A., Tournay, C., Davodeau, F., Ro-magne, F., Bonneville, M., and Lang, F. Efficient detection and immunomagnetic sorting of specific T cells using mul-timers of MHC class I and peptide with reduced CD8 binding. Nat Med 6, 707, 2000.
31. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., and Roder, J.C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci\USA 90, 8424, 1993.
32. Kaattari, S.L., and Rittenberg, M.B. Concanavalin A supernatant recruits antigen-insensitive IgG memory B lymphocyte precursors into an antigen-sensitive precursor pool. J Immunol 128, 720, 1982.
33. Taqvi, S., and Roy, K. Influence of scaffold physical properties and stromal cell coculture on hematopoietic differentiation of mouse embryonic stem cells. Biomaterials 27, 6024, 2006.
34. Baird, A.M., Gerstein, R.M., and Berg, L.J. The role of cyto-kine receptor signaling in lymphocyte development. Curr Opin Immunol 11, 157, 1999.
35. Barber, D.L., Wherry, E.J., and Ahmed, R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 171, 27, 2003.
36. Liu, L., Chahroudi, A., Silvestri, G., Wernett, M.E., Kaiser, W.J., Safrit, J.T., Komoriya, A., Altman, J.D., Packard, B.Z., and Feinberg, M.B. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluoro-genic caspase substrates. Nat Med 8, 185, 2002.
37. Fry, T.J., and Mackall, C.L. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 174, 6571, 2005.
38. Hofmeister, R., Khaled, A.R., Benbernou, N., Rajnavolgyi, E., Muegge, K., and Durum, S.K. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev 10, 41, 1999.
39. Muegge, K., Vila, M.P., and Durum, S.K. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science 261, 93, 1993.
40. Raulet, D.H., Hunig, T., and Parker, D.C. T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants. J Immunol 128, 908, 1982.
41. Jerome, K.R., Sloan, D.D., and Aubert, M. Measurement of CTL-induced cytotoxicity: the caspase 3 assay. Apoptosis 8, 563, 2003.
42. Nemazee, D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 6, 728, 2006.
43. Petrie, H.T., Livak, F., Burtrum, D., and Mazel, S. T cell receptor gene recombination patterns and mechanisms: cell death, rescue, and T cell production. J Exp Med 182, 121, 1995.
44. \+ T cells. Immunity 9, 637, 1998.
45. Yokosuka, T., Takase, K., Suzuki, M., Nakagawa, Y., Taki, S., Takahashi, H., Fujisawa, T., Arase, H., and Saito, T. Predominant role of T cell receptor (TCR)-alpha chain in forming preimmune TCR repertoire revealed by clonal TCR reconstitution system. J Exp Med 195, 991, 2002.
46. Bas, A., Hammarstrom, S.G., and Hammarstrom, M.L. Extrathymic TCR gene rearrangement in human small intestine: identification of new splice forms of recombination activating gene-1 mRNA with selective tissue expression. J Immunol 171, 3359, 2003.
47. Zakrzewski, J.L., Kochman, A.A., Lu, S.X., Terwey, T.H., Kim, T.D., Hubbard, V.M., Muriglan, S.J., Suh, D., Smith, O.M., Grubin, J., Patel, N., Chow, A., Cabrera-Perez, J., Radhakrishnan, R., Diab, A., Perales, M.A., Rizzuto, G., Menet, E., Pamer, E.G., Heller, G., Zuniga-Pflucker, J.C.
48. Alpdogan, O., and van Den Brink, M.R. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after alloge-neic hematopoietic stem cell transplantation. Nat Med 12, 1039, 2006.
49. Gurdon, J.B., Byrne, J.A., and Simonsson, S. Nuclear repro-gramming and stem cell creation. Proc Natl Acad Sci\USA 100 Suppl 1, 11819, 2003.
50. Okita, K., Ichisaka, T., and Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313, 2007.
51. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B.E., and Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318, 2007.